Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Pinorubin (pirarubicin)
i
Other names:
1609RB, THP-ADM, THP-DOX
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Sanofi
Drug class:
RNA synthesis inhibitor, DNA topoisomerase inhibitor
Related drugs:
‹
dactinomycin (8)
lyso-thermosensitive liposomal doxorubicin (0)
OVI-123 (0)
echinomycin (0)
PM14 (0)
NP-ACT D (0)
PCS3117 (0)
SNB-101 (2)
L-ANN (2)
rubitecan (1)
CBP-1019 (0)
E7040 (0)
EGFREDVDox (0)
SSS22 (0)
dactinomycin (8)
lyso-thermosensitive liposomal doxorubicin (0)
OVI-123 (0)
echinomycin (0)
PM14 (0)
NP-ACT D (0)
PCS3117 (0)
SNB-101 (2)
L-ANN (2)
rubitecan (1)
CBP-1019 (0)
E7040 (0)
EGFREDVDox (0)
SSS22 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TOP2A overexpression
Adrenal Cortex Carcinoma
TOP2A overexpression
Adrenal Cortex Carcinoma
pirarubicin
Sensitive: D – Preclinical
pirarubicin
Sensitive
:
D
pirarubicin
Sensitive: D – Preclinical
pirarubicin
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login